Literature DB >> 19109212

Perceived advantages and disadvantages of using drug samples in a university hospital center: a case study.

Lyne Tardif1, Benoît Bailey, Jean-François Bussières, Denis Lebel, Geneviève Soucy.   

Abstract

BACKGROUND: The distribution of drug samples is both permitted and a common practice in Canada and the US. The impact of this strategy on healthcare workers' opinions and habits is a reason for concern.
OBJECTIVE: To evaluate the perceived advantages and disadvantages of using drug samples in a university hospital center.
METHOD: An observational, descriptive case study was conducted in a 500-bed university hospital center between October 18 and November 1, 2007. To obtain feedback from the healthcare staff, our research team, which was made up of a physician, pharmacy resident, 2 pharmacists, and a student in health administration, designed a 26-question survey using a Likert scale (fully agree, partially agree, partially disagree, totally disagree, do not know). The questions focused on 8 different variables (rapid treatment initiation, free cost and availability, practicality of use, patient risk, pharmacist's role, impact on choice of treatment, storage and stock management, risk of pilfering).
RESULTS: In total, 39 physicians, 18 medical residents, 17 medical clerks, 83 nurses, and 23 pharmacists working in various healthcare units and outpatient clinics (N = 180) agreed to take part in the survey and fill out the questionnaire. Generally speaking, there was a high degree of variation among the professional groups in their levels of agreement with the statements on the questionnaire. For example, 71% of the nurses, 43% of the physicians, 71% of the medical residents, and 36% of the medical clerks believed that drug samples encouraged treatment adherence, whereas only 17% of the pharmacists were of this opinion.
CONCLUSIONS: Our results show that the perceived advantages and risks of using drug samples vary by healthcare provider group and in terms of exposure or nonexposure to their use. Concerned professionals must be provided with this information and strict measures must be instituted to ensure patient security.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19109212     DOI: 10.1345/aph.1L154

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  5 in total

1.  Awareness of the Food and Drug Administration's Bad Ad Program and Education Regarding Pharmaceutical Advertising: A National Survey of Prescribers in Ambulatory Care Settings.

Authors:  Amie C O'Donoghue; Vanessa Boudewyns; Kathryn J Aikin; Emily Geisen; Kevin R Betts; Brian G Southwell
Journal:  J Health Commun       Date:  2015-07-15

2.  Availability of drug samples in hospitals: opportunity or threat?

Authors:  Isabelle Barthélémy; Yemsoktheavy Khvan; Tina Ly; Suzanne Atkison; Denis Lebel; Jean-François Bussières
Journal:  Can J Hosp Pharm       Date:  2013-01

3.  Drug samples in family medicine teaching units: a cross-sectional descriptive study: Part 3: availability and use of drug samples in Quebec.

Authors:  Marie-Thérèse Lussier; Fatoumata Binta Diallo; Pierre Pluye; Roland Grad; Andréa Lessard; Caroline Rhéaume; Michel Labrecque
Journal:  Can Fam Physician       Date:  2018-12       Impact factor: 3.275

Review 4.  Medical students' exposure to and attitudes about the pharmaceutical industry: a systematic review.

Authors:  Kirsten E Austad; Jerry Avorn; Aaron S Kesselheim
Journal:  PLoS Med       Date:  2011-05-24       Impact factor: 11.069

5.  Exposure to the drug company marketing in Greece: Interactions and attitudes in a non-regulated environment for medical students.

Authors:  Magdalini Filippiadou; Dimitrios Kouvelas; Georgios Garyfallos; Ioannis Tsakiridis; Dimitrios Tzachanis; Dimitrios Spachos; Georgios Papazisis
Journal:  Ann Med Surg (Lond)       Date:  2017-05-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.